Theseus Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Revenue	-	-	-	0.26	-	0.09	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-57.85%	Upgrade
Cost of Revenue	1.46	1.38	0.38	0.4	0.13	0.66	Upgrade
Gross Profit	-1.46	-1.38	-0.38	-0.15	-0.13	-0.58	Upgrade
Selling, General & Admin	1.51	2.22	3.1	4.05	1.74	1.92	Upgrade
Research & Development	0.7	0.79	0.44	0.54	0.41	0.75	Upgrade
Other Operating Expenses	-1.3	-1.44	-0.8	-0.6	-0.59	-0.92	Upgrade
Operating Expenses	2.05	2.71	3.79	4.66	1.88	2.25	Upgrade
Operating Income	-3.51	-4.09	-4.18	-4.81	-2.01	-2.83	Upgrade
Interest Expense	-0.11	-0.08	-0.1	-0.31	-0.1	-0.61	Upgrade
Interest & Investment Income	0.01	0.02	0.04	0.01	0	0	Upgrade
Other Non Operating Income (Expenses)	1.28	1.07	0.06	0.15	-0.47	0.05	Upgrade
EBT Excluding Unusual Items	-2.33	-3.08	-4.17	-4.96	-2.58	-3.38	Upgrade
Gain (Loss) on Sale of Assets	-0.06	-0	-	-0.23	-	-	Upgrade
Asset Writedown	-0.75	-0.63	-0.28	-	-	-0.06	Upgrade
Other Unusual Items	-	-	0.04	0.01	0.11	-0.53	Upgrade
Pretax Income	-3.14	-3.71	-4.42	-5.18	-1.87	-2.07	Upgrade
Net Income	-3.14	-3.71	-4.42	-5.18	-1.87	-2.07	Upgrade
Net Income to Common	-3.14	-3.71	-4.42	-5.18	-1.87	-2.07	Upgrade
Shares Outstanding (Basic)	2,005	2,005	1,596	1,238	826	436	Upgrade
Shares Outstanding (Diluted)	2,005	2,005	1,596	1,238	826	436	Upgrade
Shares Change (YoY)	15.65%	25.62%	28.94%	49.76%	89.58%	22.63%	Upgrade
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	Upgrade
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	Upgrade
Free Cash Flow	-2.09	-2.9	-3	-5.58	-3.66	-2.08	Upgrade
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.01	-0.00	-0.01	Upgrade
Gross Margin	-	-	-	-56.55%	-	-	Upgrade
Operating Margin	-	-	-	-1866.54%	-	-3232.10%	Upgrade
Profit Margin	-	-	-	-2010.44%	-	-2364.64%	Upgrade
Free Cash Flow Margin	-	-	-	-2164.71%	-	-2380.85%	Upgrade
EBITDA	-2.51	-3.09	-3.28	-4.28	-1.84	-2.6	Upgrade
D&A For EBITDA	1	1	0.9	0.52	0.17	0.23	Upgrade
EBIT	-3.51	-4.09	-4.18	-4.81	-2.01	-2.83	Upgrade
Revenue as Reported	1.31	1.46	0.87	0.93	1.3	3.06	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.